Emergency and Critical Care Medical Center, Osaka Police Hospital, Kitayama-cho 10-31 Tennouji-ku, Osaka 543-0035, Japan.
Resuscitation. 2013 Jan;84(1):54-9. doi: 10.1016/j.resuscitation.2012.05.027. Epub 2012 Jun 15.
It is unclear whether the basic life support (BLS) and advanced life support (ALS) pre-hospital termination of resuscitation (TOR) rules developed in North America can be applied successfully to patients with out-of-hospital cardiac arrest (OHCA) in other countries.
To assess the performance of the BLS and ALS TOR in Japan.
Retrospective nationwide, population-based, observational cohort study of consecutive OHCA patients with emergency responder resuscitation attempts from 1 January 2005 to 31 December 2009 in Japan. The BLS TOR rule has 3 criteria whereas the ALS TOR rule includes 2 additional criteria. We extracted OHCA patients meeting all criteria for each TOR rule, and calculated the specificity and positive predictive value (PPV) of each TOR rule for identifying OHCA patients who did not have neurologically favorable one-month survival.
During the study-period, 151,152 cases were available to evaluate the BLS TOR rule, and 137,986 cases to evaluate the ALS TOR rule. Of 113,140 patients that satisfied all three criteria for the BLS TOR rule, 193 (0.2%) had a neurologically favorable one-month survival. The specificity of BLS TOR rule was 0.968 (95% CI: 0.963-0.972), and the PPV was 0.998 (95% CI: 0.998-0.999) for predicting lack of neurologically favorable one-month survival. Of 41,030 patients that satisfied all five criteria for the ALS TOR rule, just 37 (0.1%) had a neurologically favorable one-month survival. The specificity of ALS TOR rule was 0.981 (95% CI: 0.973-0.986), and the PPV was 0.999 (95% CI: 0.998-0.999) for predicting lack of neurologically favorable one-month survival.
The prehospital BLS and ALS TOR rules performed well in Japan with high specificity and PPV for predicting lack of neurologically favorable one-month survival in Japan. However, the specificity and PPV were not 1000 and we have to develop more specific TOR rules.
在北美的基本生命支持(BLS)和高级生命支持(ALS)院前复苏终止(TOR)规则是否可以成功应用于其他国家的院外心脏骤停(OHCA)患者尚不清楚。
评估日本的 BLS 和 ALS TOR 的表现。
这是一项回顾性的全国性、基于人群的观察性队列研究,纳入了 2005 年 1 月 1 日至 2009 年 12 月 31 日期间日本急救员复苏尝试的连续 OHCA 患者。BLS TOR 规则有 3 个标准,而 ALS TOR 规则则包括另外 2 个标准。我们提取了符合每个 TOR 规则所有标准的 OHCA 患者,并计算了每个 TOR 规则对识别无神经功能良好的一个月生存率的 OHCA 患者的特异性和阳性预测值(PPV)。
在研究期间,共有 151152 例患者可用于评估 BLS TOR 规则,137986 例患者可用于评估 ALS TOR 规则。在符合 BLS TOR 规则的 113140 例患者中,有 193 例(0.2%)有一个月的神经功能良好的生存率。BLS TOR 规则的特异性为 0.968(95%CI:0.963-0.972),对预测缺乏神经功能良好的一个月生存率的阳性预测值为 0.998(95%CI:0.998-0.999)。在符合 ALS TOR 规则的所有 5 个标准的 41030 例患者中,仅有 37 例(0.1%)有一个月的神经功能良好的生存率。ALS TOR 规则的特异性为 0.981(95%CI:0.973-0.986),对预测缺乏神经功能良好的一个月生存率的阳性预测值为 0.999(95%CI:0.998-0.999)。
在日本,BLS 和 ALS TOR 的院前规则表现良好,具有高特异性和阳性预测值,可预测日本患者一个月内神经功能不良的生存率。然而,特异性和阳性预测值并非 100%,我们必须制定更具特异性的 TOR 规则。